Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells

Loraine Kay D. Cabral(Fondazione Italiana Fegato), Caecilia Sukowati(Unknown)
International Journal of Molecular Sciences
July 6, 2025
Cited by 3


Related Papers